IL13RA2 and neoplasm: Christine E. Brown reported an increase in the number of cytokines and immune cells in the CSF and the regression of tumor cells in the spinal canal and spine after studying a patient with recurrent multifocal GBM treated with IL-13Rα2- CAR-T [47].